Evoke Pharma, Inc (EVOK)

Etorro trading 970x250
Evoke Pharma, Inc (EVOK) Logo

About Evoke Pharma, Inc

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California. Address: 420 Stevens Avenue, Solana Beach, CA, United States, 92075

Evoke Pharma, Inc News and around…

Latest news about Evoke Pharma, Inc (EVOK) common stock and company :

Evoke Pharma and EVERSANA Announce Positive Findings from GIMOTI® Market Research Study
20 Oct, 2021 Yahoo! Finance

Evoke Pharma, Inc. Trend Across Waves for Proportion of Respondents Who Are Highly Familiar With GIMOTI (score of 4 or 5 out of 5) Health care practitioners’ perception of nasal route of administration similar to IV; 92% intend to prescribe GIMOTI Evoke attending American College of Gastroenterology (ACG) Annual Conference in Las Vegas, October 22-27, 2021 SOLANA BEACH, Calif. and CHICAGO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company foc

12 Health Care Stocks Moving In Thursday's Pre-Market Session
14 Oct, 2021 FinancialContent

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 34.63% to $12.71 during Thursday's pre-market session. ...

Looking Into Evoke Pharma's Return On Capital Employed
30 Sep, 2021 FinancialContent

According to Benzinga Pro data, during Q2, Evoke Pharma (NASDAQ:EVOK) posted sales of $236.63 thousand. Earnings were up 16.27%, but ...

Evoke Pharma’s Commercial Partner EVERSANA, Receives PM360’s Trailblazer Initiative Award for Innovation in Healthcare Marketing for GIMOTI
29 Sep, 2021 FinancialContent
Evoke Pharma (NASDAQ:EVOK) Has Debt But No Earnings; Should You Worry?
10 Sep, 2021 Yahoo! Finance

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Evoke Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
01 Sep, 2021 FinancialContent
12 Health Care Stocks Moving In Monday's Pre-Market Session
16 Aug, 2021 FinancialContent

Gainers ADMA Biologics (NASDAQ:ADMA) stock rose 18.79% to $1.77 during Monday's pre-market session. The ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
16 Aug, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! It's been a while but we're back at it with a look at the biggest pre-market stock movers for Monday. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

24 Stocks Moving in Monday's Pre-Market Session
16 Aug, 2021 FinancialContent

Gainers Enlivex Therapeutics Ltd. (NASDAQ: ENLV) shares rose 26.6% to $12.87 in pre-market trading after the company disclosed ...

12 Health Care Stocks Moving In Friday's Intraday Session
13 Aug, 2021 FinancialContent

Gainers Biolase (NASDAQ:BIOL) stock increased by 38.01% to $0.87 during Friday's regular session. Trading volume for ...

What's Up With Evoke Pharma's Stock Popping Off Friday?
13 Aug, 2021 FinancialContent

Evoke Pharma Inc (NASDAQ: EVOK) shares are trading higher by 23.1% at $1.38 after the company reported better-than-expected ...

12 Health Care Stocks Moving In Friday's Pre-Market Session
13 Aug, 2021 FinancialContent

Gainers Biolase (NASDAQ:BIOL) stock moved upwards by 42.49% to $0.9 during Friday's pre-market session. The ...

Evoke Pharma Reports Second Quarter 2021 Financial Results
12 Aug, 2021 FinancialContent
Evoke Pharma to Report Second Quarter 2021 Financial Results on August 12, 2021
05 Aug, 2021 FinancialContent
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
05 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Evoke Pharma and EVERSANA Announce Support of The International Foundation for Gastrointestinal Disorders’ (IFFGD) August Gastroparesis Awareness Month
02 Aug, 2021 FinancialContent

Participating and Sponsorship in Upcoming Digestive Health Virtual Walk

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
27 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

12 Health Care Stocks Moving In Monday's After-Market Session
26 Jul, 2021 FinancialContent

Gainers Eyegate Pharmaceuticals (NASDAQ:EYEG) stock increased by 25.64% to $3.92 during Monday's after-market session. The company's ...

Evoke Pharma Launches Gimoti® Patient and Physician Experience Program
14 Jul, 2021 FinancialContent

Program intends to expand awareness and trial of GIMOTI among non-prescribing healthcare providers

12 Health Care Stocks Moving In Monday's Intraday Session
12 Jul, 2021 FinancialContent

Gainers Celldex Therapeutics (NASDAQ:CLDX) stock increased by 21.35% to $39.33 during Monday's regular session. ...

Evoke Pharma, EVERSANA and The International Foundation for Gastrointestinal Disorders Announce Membership into IFFGD’s Industry Council
29 Jun, 2021 FinancialContent

Extends commitment toward supporting patients experiencing Diabetic Gastroparesis through focused collaborations and Sponsorship of the 30th Anniversary Digestive Health Virtual Walk

Evoke Pharma and EVERSANA Announce Positive Findings from Second GIMOTI® Market Research Study
15 Jun, 2021 FinancialContent

Results demonstrate continued increased awareness and intent to prescribe GIMOTI

Evoke Pharma Announces FDA Orange Book Listing of U.S. Patent for Gimoti®
08 Jun, 2021 FinancialContent
Evoke Pharma Announces Issuance of a New U.S. Patent Covering Methods of Use for Gimoti®
02 Jun, 2021 FinancialContent
Evoke Pharma and EVERSANA Launch Social Media Campaign for Gimoti® Nasal Spray
27 May, 2021 FinancialContent
The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal
25 May, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Evoke Pharma Appoints Vickie Reed to Board of Directors
14 May, 2021 FinancialContent
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
14 May, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

77 Biggest Movers From Yesterday
14 May, 2021 FinancialContent

Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77. Moxian, Inc. (NASDAQ: MOXC) jumped ...

Mid-Afternoon Market Update: Dow Jumps Over 500 Points; ContextLogic Shares Plunge
13 May, 2021 FinancialContent

Toward the end of trading Thursday, the Dow traded up 1.57% to 34,115.36 while the NASDAQ rose 0.78% to 13,133.31. The S&P also ...

Evoke Pharma, Inc (EVOK) is a NASDAQ Common Stock listed in , ,

970x250